Nitric oxide-induced inhibition of mouse paw edema: Involvement of soluble guanylate cyclase and potassium channels

Inflammation Research

Volumn 51, Issue 8, 2002, Pages 377-384

  Fernandes, D ^a   Da Silva Santos, J E ^a   Assreuy, J ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Guanylate cyclase; Inflammation; Paw edema; Plasma leakage; Potassium channel

Indexed keywords

BRADYKININ; CARRAGEENAN; DEXTRAN SULFATE; GUANYLATE CYCLASE; METHYLENE BLUE; MYELOPEROXIDASE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; POTASSIUM CHANNEL; TETRYLAMMONIUM;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; INFLAMMATION; MOUSE; NONHUMAN; PAW EDEMA;

EID: 0036677383     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00000318     Document Type: Article

References (37)

1. Nitric oxide: Physiology, pathophysiology and pharmacology
2. The role of nitric oxide in inflammation
3. The microcirculation and inflammation: Modulation of leukocyte-endothelial adhesion
4. Nitric oxide: An endogenous modulator of leukocyte adhesion
5. Nitric oxide attenuates leukocyte-endothelial interaction via p-selectin in splanchnic ischemia-reperfusion
6. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines
7. Nitric oxide modulates microvascular permeability
8. Signal transduction mechanism involving nitric oxide
9. Role of nitric oxide and K+ channels in vascular hyporeactivity induced by endotoxin
10. Long-lasting changes of rat blood pressure to vasoconstrictors and vasodilators induced by nitric oxide donor infusion: Involvement of potassium channels
11. Involvement of soluble guanylate cyclase and calcium-activated potassium channels in the long-lasting hyporesponsiveness to phenylephrine induced by nitric oxide in the rat aorta
12. Biochemistry of nitric oxide and its redox-activated
13. Nitric oxide regulates monocyte chemotactic protein-1
14. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide
15. Involvement of B1 and B2 receptors in bradykinin-induced rat paw oedema
16. A new method for measuring variations of rat paw volume
17. An unusually stable thionitrite from N-acetyl-D,L-penicilamine; X-ray crystal and molecular structure of 2-(acetylamino)-2-carboxy-1,1-dimethylethyl thionitrite
18. Studies of mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine
19. Screens for antiinflammatory drugs
20. The mechanism of the inflammatory effect of carrageenin
21. Histopathological and pharmacological study of carrageenin inflammation in the rat
22. Mouse paw oedema. A new model for inflammation?
23. Oral antinociception and oedema inhibition produced by NPC 18884, a non-peptidic bradykinin B2 receptor antagonist
24. Intrinsic prostacyclin contributes to exudation induced by bradykinin or carrageenin: A study on the paw oedema induced in IP-receptor-deficient mice
25. Anti-inflammatory testing methods: Comparative evaluation of mice and rats
26. New insights into the regulation of inducible nitric oxide synthesis
27. Induction of cyclooxygenase and nitric oxide in inflammation
28. Estimation of nitric oxide production and reaction rates in tissue by use of a mathematical model
29. Nitric oxide inhibits numerous features of mast cell-induced inflammation
30. Nitric oxide inhibits microvascular protein leakage induced by leukocyte adhesion-independent and adhesion-dependent inflammatory mediators
31. Inhibition of nitric oxide synthesis increases venular permeability and alters endothelial actin cytoskeleton
32. Inducible Nitric Oxide: An autoregulatory feedback inhibitor of vascular inflammation
33. Inhibition of nitric oxide production: Mechanisms of vascular albumin leakage
34. Pharmacokinetics and disposition: Pharmacokinetics and organ distribution of intravenous and oral methylene blue
35. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle
36. Nitric oxide and cGMP cause vasorelaxation by activation of charybdotoxin-sensitive K channels by cGMP-dependent protein kinase